Digital health

Digital Therapeutics with Intelleq

Intelleq brings expertise in Digital Health and Therapeutics through experience and partnership with leaders in the health care and information technology sectors.

At the intersection of these sectors Digital Therapeutics brings innovation through the use of artificial intelligence, machine learning, and big data analytics to find solutions in health care.

Outcome-based innovation is at the core of our philosophy in product development for Digital Health. We see the end goal of improving the condition and lifestyle of those who struggle with chronic illnesses as the priority in any project.

decorative image

Intelleq brings together new technologies in mobile application development, wearable device configuration and integration, as well as artificial intelligence to find better ways to treat disease.

We increase the effectiveness of pharmaceutical treatment by creating “stickiness” with patients, meaning they continue to actively manage their chronic conditions with the help of mobile applications and wearable devices.

Healthcare and pharmaceutical organizations can find value, reduce costs and improve quality of care and products by implementing Digital Health solutions to reach their patients. There is an ocean of health data that can be used to drive these outcomes with Intelleq

decorative image

Please visit product website at https://AmalgamRX.com

About Intelleq

Intelleq, strives to provide and develop technology solutions for organizations to help them overcome any challenges and grow in their digital journey. Headquartered at Baltimore,MD our professionals are located across US and India.

Intelleq experts help provide organizations in developing cutting-edge solutions using the latest technologies such as Artificial Intelligence, Blockchain, Cloud Services, DevOps, and Test Automation. We aim to provide solutions and services related to Digital & Quality Assurance that will help enterprises build the best quality products at reduced costs and faster time-to-market.

Reach us at [email protected]

Contact Info